Allogeneic hematopoietic stem cell transplantation is the optimal care for patients with high-
risk or intermediate-acute myeloid leukemia. In patients lacking matched sibling donor …

Primary refractory or relapsed acute myeloid leukemia is associated with a dismal
prognosis. Allogeneic stem cell transplantation is the only therapeutic option that offers …

We compared the treatment-related mortality, relapse rate, disease-free survival (DFS), and
overall survival (OS) by cytogenetic risk group of 261 patients with acute myeloid leukemia …

HLA-haploidentical hematopoietic cell transplantation (Haplo-HCT) using
posttransplantation cyclophosphamide (PT-Cy) has improved donor availability. However, a …

Background Non-T-cell depleted haploidentical hematopoietic stem cell transplantation
(HaploSCT) is being increasingly used in acute lymphoblastic leukemia (ALL) with …

This study aimed to investigate graft-versus-leukemia (GVL) of haploidentical donor (HID)
compared with HLA-matched sibling donor (MSD) for high-risk acute myeloid leukemia (H …

Background In the absence of a HLA-matched related or matched unrelated donor,
allogeneic stem cell transplantation (allo-SCT) from mismatched unrelated donors or …

Refractory or relapsed acute myeloid leukemia (R/R-AML) has poor prognosis. Allogeneic
hematopoietic stem-cell transplantation (HSCT) may provide cure in this scenario. We …

Unmanipulated haploidentical allogeneic stem cell transplantation (Allo-SCT) has become
an attractive alternative for patients lacking HLA-matched sibling or unrelated donors …

“Beijing group” has pioneered a different approach with T-cell replete HID, intensive
myeloablation, a combination of G-CSF-primed bone marrow plus peripheral blood as the …